Epidemiology of endometrial carcinoma: Etiologic importance of hormonal and metabolic influences

Ashley S. Felix, Hannah P. Yang, Daphne W. Bell, Mark E. Sherman

Research output: Chapter in Book/Report/Conference proceedingChapter

16 Citations (Scopus)

Abstract

Endometrial carcinoma is the most common gynecologic cancer in developed nations, and the annual incidence is projected to increase, secondary to the high prevalence of obesity, a strong endometrial carcinoma risk factor. Although endometrial carcinomas are etiologically, biologically, and clinically diverse, hormonal and metabolic mechanisms are particularly strongly implicated in the pathogenesis of endometrioid carcinoma, the numerically predominant subtype. The centrality of hormonal and metabolic disturbances in the pathogenesis of endometrial carcinoma, combined with its slow development from well-characterized precursors in most cases, offers a substantial opportunity to reduce endometrial carcinoma mortality through early detection, lifestyle modification, and chemoprevention. In this chapter, we review the epidemiology of endometrial carcinoma, emphasizing theories that link risk factors for these tumors to hormonal and metabolic mechanisms. Future translational research opportunities related to prevention are discussed.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages3-46
Number of pages44
Volume943
DOIs
StatePublished - Jan 1 2017

Publication series

NameAdvances in Experimental Medicine and Biology
Volume943
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Fingerprint

Epidemiology
Endometrial Neoplasms
Tumors
Endometrioid Carcinoma
Translational Medical Research
Chemoprevention
Developed Countries
Life Style
Neoplasms
Obesity
Mortality
Incidence

Keywords

  • Adipokines
  • Endometrial carcinoma
  • Estrogen
  • Hormones
  • Incidence trend
  • Infl ammation
  • Insulin
  • Progesterone
  • Risk factors

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Felix, A. S., Yang, H. P., Bell, D. W., & Sherman, M. E. (2017). Epidemiology of endometrial carcinoma: Etiologic importance of hormonal and metabolic influences. In Advances in Experimental Medicine and Biology (Vol. 943, pp. 3-46). (Advances in Experimental Medicine and Biology; Vol. 943). Springer New York LLC. https://doi.org/10.1007/978-3-319-43139-0_1

Epidemiology of endometrial carcinoma : Etiologic importance of hormonal and metabolic influences. / Felix, Ashley S.; Yang, Hannah P.; Bell, Daphne W.; Sherman, Mark E.

Advances in Experimental Medicine and Biology. Vol. 943 Springer New York LLC, 2017. p. 3-46 (Advances in Experimental Medicine and Biology; Vol. 943).

Research output: Chapter in Book/Report/Conference proceedingChapter

Felix, AS, Yang, HP, Bell, DW & Sherman, ME 2017, Epidemiology of endometrial carcinoma: Etiologic importance of hormonal and metabolic influences. in Advances in Experimental Medicine and Biology. vol. 943, Advances in Experimental Medicine and Biology, vol. 943, Springer New York LLC, pp. 3-46. https://doi.org/10.1007/978-3-319-43139-0_1
Felix AS, Yang HP, Bell DW, Sherman ME. Epidemiology of endometrial carcinoma: Etiologic importance of hormonal and metabolic influences. In Advances in Experimental Medicine and Biology. Vol. 943. Springer New York LLC. 2017. p. 3-46. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-3-319-43139-0_1
Felix, Ashley S. ; Yang, Hannah P. ; Bell, Daphne W. ; Sherman, Mark E. / Epidemiology of endometrial carcinoma : Etiologic importance of hormonal and metabolic influences. Advances in Experimental Medicine and Biology. Vol. 943 Springer New York LLC, 2017. pp. 3-46 (Advances in Experimental Medicine and Biology).
@inbook{45f9b11f914a4046a82c700ce5a369a0,
title = "Epidemiology of endometrial carcinoma: Etiologic importance of hormonal and metabolic influences",
abstract = "Endometrial carcinoma is the most common gynecologic cancer in developed nations, and the annual incidence is projected to increase, secondary to the high prevalence of obesity, a strong endometrial carcinoma risk factor. Although endometrial carcinomas are etiologically, biologically, and clinically diverse, hormonal and metabolic mechanisms are particularly strongly implicated in the pathogenesis of endometrioid carcinoma, the numerically predominant subtype. The centrality of hormonal and metabolic disturbances in the pathogenesis of endometrial carcinoma, combined with its slow development from well-characterized precursors in most cases, offers a substantial opportunity to reduce endometrial carcinoma mortality through early detection, lifestyle modification, and chemoprevention. In this chapter, we review the epidemiology of endometrial carcinoma, emphasizing theories that link risk factors for these tumors to hormonal and metabolic mechanisms. Future translational research opportunities related to prevention are discussed.",
keywords = "Adipokines, Endometrial carcinoma, Estrogen, Hormones, Incidence trend, Infl ammation, Insulin, Progesterone, Risk factors",
author = "Felix, {Ashley S.} and Yang, {Hannah P.} and Bell, {Daphne W.} and Sherman, {Mark E.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/978-3-319-43139-0_1",
language = "English (US)",
volume = "943",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "3--46",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Epidemiology of endometrial carcinoma

T2 - Etiologic importance of hormonal and metabolic influences

AU - Felix, Ashley S.

AU - Yang, Hannah P.

AU - Bell, Daphne W.

AU - Sherman, Mark E.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Endometrial carcinoma is the most common gynecologic cancer in developed nations, and the annual incidence is projected to increase, secondary to the high prevalence of obesity, a strong endometrial carcinoma risk factor. Although endometrial carcinomas are etiologically, biologically, and clinically diverse, hormonal and metabolic mechanisms are particularly strongly implicated in the pathogenesis of endometrioid carcinoma, the numerically predominant subtype. The centrality of hormonal and metabolic disturbances in the pathogenesis of endometrial carcinoma, combined with its slow development from well-characterized precursors in most cases, offers a substantial opportunity to reduce endometrial carcinoma mortality through early detection, lifestyle modification, and chemoprevention. In this chapter, we review the epidemiology of endometrial carcinoma, emphasizing theories that link risk factors for these tumors to hormonal and metabolic mechanisms. Future translational research opportunities related to prevention are discussed.

AB - Endometrial carcinoma is the most common gynecologic cancer in developed nations, and the annual incidence is projected to increase, secondary to the high prevalence of obesity, a strong endometrial carcinoma risk factor. Although endometrial carcinomas are etiologically, biologically, and clinically diverse, hormonal and metabolic mechanisms are particularly strongly implicated in the pathogenesis of endometrioid carcinoma, the numerically predominant subtype. The centrality of hormonal and metabolic disturbances in the pathogenesis of endometrial carcinoma, combined with its slow development from well-characterized precursors in most cases, offers a substantial opportunity to reduce endometrial carcinoma mortality through early detection, lifestyle modification, and chemoprevention. In this chapter, we review the epidemiology of endometrial carcinoma, emphasizing theories that link risk factors for these tumors to hormonal and metabolic mechanisms. Future translational research opportunities related to prevention are discussed.

KW - Adipokines

KW - Endometrial carcinoma

KW - Estrogen

KW - Hormones

KW - Incidence trend

KW - Infl ammation

KW - Insulin

KW - Progesterone

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=85006069170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006069170&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-43139-0_1

DO - 10.1007/978-3-319-43139-0_1

M3 - Chapter

C2 - 27910063

AN - SCOPUS:85006069170

VL - 943

T3 - Advances in Experimental Medicine and Biology

SP - 3

EP - 46

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -